2020
DOI: 10.1007/s12094-020-02310-0
|View full text |Cite
|
Sign up to set email alerts
|

Impact of pre-radiation therapy quality of life in lung cancer survival: a prospective, intention-to-treat, multicenter study

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

2
10
0

Year Published

2021
2021
2024
2024

Publication Types

Select...
7
1

Relationship

0
8

Authors

Journals

citations
Cited by 9 publications
(12 citation statements)
references
References 25 publications
2
10
0
Order By: Relevance
“…The QoL scale of the EORTC was scored from 0 to 100, where higher scores in general state and functional scales represent a higher functional level, while in the symptoms scale, the higher the score, the greater symptomatology. [ 20 ]…”
Section: Methodsmentioning
confidence: 99%
“…The QoL scale of the EORTC was scored from 0 to 100, where higher scores in general state and functional scales represent a higher functional level, while in the symptoms scale, the higher the score, the greater symptomatology. [ 20 ]…”
Section: Methodsmentioning
confidence: 99%
“…Generally speaking, the efficacy of radiotherapy for most tumors is positively correlated with the dose of irradiation (13). The general principle for developing radiotherapy strategies is to maximize the dose to tumor-affected tissue while protecting healthy tissue (14).…”
Section: Discussionmentioning
confidence: 99%
“…To account for the multicollinearity of HRQOL measures, we employed principal component analysis (PCA) [1]. In looking for opportunities to test these findings, we noted that HRQOL measures have been shown to correlate with survival in a number of disease sites, including lung cancer [2][3][4][5][6][7].…”
Section: Introductionmentioning
confidence: 99%
“…Lung cancer is the leading cause of cancer-related death worldwide with 1.8 million deaths from an estimated 2.2 million new cases in 2020 [8]. HRQOL measures have been shown to correlate with survival in a number of disease sites [2][3][4][5][6][7]. However, studies are heterogenous with regard to stage, treatment, and histology, and many are limited to baseline HRQOL information [2][3][4][5][6][7].…”
Section: Introductionmentioning
confidence: 99%
See 1 more Smart Citation